The Clinical Risk Assessment report follows a previous report from Health Improvement Scotland which highlighted that patients in NHS Tayside...

17 April 2019

The National Institute for Health and Care Excellence (NICE) has today (10 April 2019) provisionally rejected breast cancer drug ribociclib in...

10 April 2019

Health Improvement Scotland has issued a report into the clinical management of breast cancer in NHS Tayside which highlights local inconsistencies...

5 April 2019

The National Institute for Health and Care Excellence (NICE) has today published draft guidance recommending breast cancer drug abemaciclib with...

2 April 2019

Mortality rates from breast cancer are predicted to fall in the UK and across Europe (except for in Poland) by 2019, according to new research...

19 March 2019

New breast cancer immunotherapy atezolizumab (Tecentriq) is to be made available in the short term for certain NHS patients with metastatic ‘triple...

15 March 2019

New monthly cancer waiting times figures have been released today by NHS England. The figures show: The two week wait for people referred with...

14 March 2019

The study, led by scientists at the Cancer Research UK Cambridge Institute and published in Nature, examined the patterns of genetic changes within...

13 March 2019

NHS England has today announced that new waiting times standards for people with urgent mental and physical needs are to be trialled across the...

11 March 2019